DRUG STUDY

Generic Brand Classification Mode of Indication Contraindication Usual Dose Actual Side Effect Nursing
Name Name Action Dose Responsibility
Antipsychotic Antagonizes Treatment -Contraindicated Schizophrenia: 10mg/ CNS: Somnolence, - Before
O Z Drug dopamine of schizophrenia with allergy to ola Initially, 5– ODT, dizziness, nervousness, administration:
L Y and serotonin nzapine, myelopr 10 mg PO 10DT headache, akathisia, per Observe for 10R’s
A P type 2 in the Treatment of acute oliferative disorde daily, increase now sonality properly.
N R CNS. Also mixed or manic rs, severe to 10 mg PO disorders, tardive dyski
Z E has episodes associated CNS depression, daily within nesia, neuroleptic malig -Instruct to take this
A X anticholinergi with bipolar 1 disorder comatose several days; nant syndrome drug exactly as
P A c, and maintenance of states, and may be prescribed; do not
I antihistamine bipolar 1 disorder as lactation. increased by 5 CV: Orthostatic hypote change dose without
N , and anti- monotherapy, or mg/day at 1- nsion, peripheral consulting your health
E alpha1- combined with lithium -Use cautiously in wk intervals to edema, tachycardia care provider
adrenergic or valproate elderly or achieve
effects. debilitated desired effect. GI: Constipation, abdo -Monitor for the many
Treatment of agitation patients, or with Do not exceed minal pain possible drug
associated CV or 20 mg/day. interactions before
with schizophrenia an cerebrovascular Respiratory: Cough beginning therapy.
d bipolar 1 mania disease, dehydrati and pharyngitis.
(injection) on, seizure disord -Monitor elderly
ers, Alzheimer’s Other: Fever, weight patients
disease, prostate gain, joint pain, for dehydration and
enlargement, development institute remedial
narrow-angle of diabetes mellitus measures promptly;
glaucoma, history sedation and
of decreased sensation of
paralytic ileus or thirst related to CNS
breast cancer, effects of drug can
pregnancy; lead to dehydration.
phenylketonuria
(if using orally
disintegrating -Encourage patient to
tablets, contain void before taking the
phenylalanine). drug to help
decrease anticholinerg
ic effects of urinary
retention.

-Monitor for
elevations of
temperature and
differentiate
between infection and
neuroleptic malignant
syndrome.

-Monitor for
orthostatic hypotensio
n and provide
appropriate safety
measures as needed.

-Monitor patient
regularly for signs and
symptoms of diabetes
mellitus.

-Report lethargy,
weakness, fever, sore
throat, malaise, mouth
ulcers,
and flulike symptoms.